Educations

Diversity and Justice Award Renamed in Honor of ASAM Past President Lawrence S. Brown Jr., MD

Lawrence S. Brown, Jr., MD The American Society of Addiction Medicine (ASAM) has renamed its Diversity, Equality, Inclusion, and Justice Award in honor of Lawrence S. Brown, Jr., MD, MPH, FACP, DFASAM, president of ASAM from 2002–2005 and a national leader in public health, addiction treatment, and research.

Educations

Amplifying Addiction Medicine’s Voice in the House of Medicine

Discover how ASAM's delegation helps shape AMA advocacy priorities for addiction medicine with Alternate Delegate Dr. Sophia Peng.

Educations

It Takes a Team: One Member’s Mission to Empower All Disciplines Involved in Addiction Care

Finding Purpose in Integrated Care. While Judith obtained her X-waiver in 2019 to prescribe buprenorphine for opioid use disorder, she wasn’t immediately using it.

Educations

One Fellowship Director’s Excitement for the Next Generation of Addiction Medicine Professionals

At the ASAM 57th Annual Conference, ASAM recognized this year’s annual award winners for their exceptional contributions to the field of addiction medicine. Among them was Carolyn Chan, MD, MHS-MEd, program director of the University of Cincinnati Addiction Medicine Fellowship and recipient of the Fellowship Directors Award, which honors outstanding clinician educators.

Educations

Developing the Adolescents and Transition-Aged Youth volume of The ASAM Criteria®, Fourth Edition

The recently published Adolescents and Transition-Aged Youth volume of The ASAM Criteria, Fourth Edition, includes the Criteria’s first dedicated set of substance use disorder (SUD) treatment standards tailored specifically to youth. Scott Hadland, MD, MPH, FASAM, a pediatrician and co-editor of the volume, says the new standards address the highly unique needs of young people impacted by SUD.

Educations

ASAM 57th Annual Conference Preview with Planning Committee Chair Dr. Alvanzo

....

Educations

Finding Community through ASAM’s Ruth Fox Scholarship

As 2025 scholarship recipients, Dr. Iyer and her cohort received access to this past year’s Annual Conference and three years of complimentary ASAM membership. But importantly, Dr. Iyer credits the program for expanding her professional network as she prepares for the next stage of her career as an addiction specialist physician.

Educations

Inside ASAM’s Addiction Medicine Advocacy Conference with Dr. Cate Heil

Dr. Cate Heil traveled from Idaho to Washington, DC to advocate with fellow ASAM members as part of the 2025 Addiction Medicine Advocacy Conference. Get a glimpse into her busy day meeting with lawmakers and advocating for legislation to advance addiction recovery in America.

Educations

New Award Honors a Leader in Addiction Treatment and Recovery Research

For over 50 years, addiction psychiatrist and past ASAM President Marc Galanter, MD, DFASAM, has focused on demonstrating the value of helping people living with addiction find meaning and purpose in life. “We need to recognize that it is an important component in having the capacity to get better,” said Dr. Galanter, who led ASAM from 1999 to 2001.

Educations

Advancing Addiction Medicine Locally and Globally

This article talks about Dr. Hamed Ekhtiari’s journey from studying neuroscience in Iran to becoming a leader in addiction medicine. Inspired by patients in recovery, he combines clinical care with global research and innovation. As a 2023 Ruth Fox Scholar, he gained valuable connections through ASAM and promotes international collaboration to improve addiction treatment worldwide.

Educations

Reducing Federal Bureaucratic Barriers to Methadone for Opioid Use Disorder and Empowering State Innovation

This statement recommends reducing federal bureaucratic barriers to methadone treatment (MT), allowing states to design their own safe and effective models to improve access to MT to meet the needs of patients.

Educations

Honoring a Leader in Addiction Medicine Advocacy

Honoring a Leader in Addiction Medicine Advocacy Dr. Vania Rudolf, a physician specializing in addiction medicine, was honored with ASAM’s 2025 Public Policy Award for her impactful advocacy work. Over her 15-year career, she has championed equitable, evidence-based care for women with substance use disorders, driven by a deeply personal experience early in her medical training. Dr. Rudolf has led efforts to improve care in Washington State, including the COMPASSION postpartum model and statewide access to split methadone dosing for pregnant patients. Her work blends clinical care, public health, and policy to support vulnerable families and reduce stigma.

Educations

Third-Party Payment for Addiction Treatment

Educations

Ensuring the Financial Sustainability of Addiction Treatment Services in the United States

This statement underscores the need for additional policy actions to ensure that the proper infrastructure is in place to support high-quality SUD and other addiction treatment services in the right place, and at the right time.

Educations

From the Clinic to Capitol Hill: Addiction Advocacy

Educations

Why I Support ASAM: Stuart Gitlow, MD

Addiction Medicine moves into the 21st century.

Educations

Treatment of Opioid Use Disorder in Correctional Settings

Correctional settings are diverse and may face significant barriers to providing MOUD access. Therefore, ASAM advocates for systemic changes to ensure universal access to MOUD within correctional institutions.

Educations

Housing’s Role in Addressing Substance Use and Facilitating Recovery

This public policy statement recommends policies that promote stability in housing, and therefore, are important for SUD recovery and overall health and wellness.

Educations

Changing Communities One Life at a Time

After finishing his psychiatry residency in 1996, Dr. Miller’s first assignment with the U.S. Air Force was at Andrews Air Force Base’s Tri Service Addiction Recovery Center in Washington DC, the worldwide tertiary referral resource for substance use and addiction-related conditions in the Department of Defense.

Educations

Reducing Risk of Federal Investigation or Prosecution for Prescribing Controlled Addiction Medications for Legitimate Medical Purposes

Addiction medications are lifesaving treatments for addiction. This policy statement recommends various reforms to reduce the risk of federal investigation or prosecution for prescribing these medications for legitimate medical purposes.